Integer Holdings Corporation Welcomes New Board Member
Integer Holdings Corporation (NYSE: ITGR), a prominent global organization in the medical device contract development and manufacturing sector, has made headlines by appointing Michael Coyle to its Board of Directors. This strategic decision highlights Integer's commitment to enhancing its leadership team and bolstering its innovative capabilities within the medical technology field.
Michael Coyle Brings Extensive Experience
Michael Coyle is no stranger to the medical device industry, bringing an impressive background of over 40 years to his new role. His extensive experience includes prominent leadership positions in various notable companies, which makes him a valuable asset to Integer. His journey includes impactful roles at iRhythm Technologies where he served as president and CEO, as well as executive vice president and group president at Medtronic's cardio and vascular division.
Invaluable Industry Insight
Coyle's career path has equipped him with a wealth of knowledge from industry giants such as St. Jude Medical and Eli Lilly. This extensive track record will be instrumental in helping Integer navigate the complex landscape of medical device manufacturing and innovation.
A Strong Presence on Corporate Boards
In addition to his experience with Integer, Coyle currently serves on the boards of both Haemonetics Corporation and BaroPace. He has also contributed his expertise to the boards of VNUS Medical Technologies, Inc. and Volcano Corporation in the past. His diverse board experience enhances Integer's governance and strategic direction tremendously.
Academic and Patent Achievements
Coyle holds a master's degree in business administration from the prestigious Wharton School of Business at the University of Pennsylvania and a bachelor's degree from Case Western Reserve University. His contributions to the field of cardiovascular medical devices are underscored by his six U.S. patents, showcasing his innovation-driven mindset.
Strategic Vision for Growth
Integer's Board of Directors emphasizes the importance of diverse skills and backgrounds to achieve growth and drive shareholder value. Pamela Bailey, the Board Chair, expressed enthusiasm about Coyle's appointment, highlighting that his medical device expertise and proven leadership will significantly enhance the company's strategic initiatives and its corporate culture.
Collaboration for Future Success
Joseph Dziedzic, Integer's president and CEO, also shared his thoughts on Coyle's addition to the team, stating that the executive leadership team is eager to work closely with him to execute their long-term strategies. Coyle's expertise aims to align with Integer's vision of being the preferred partner for innovative medical technologies and services, ultimately enhancing patient care worldwide.
About Integer Holdings Corporation
Integer Holdings Corporation is recognized as one of the largest medical device contract development and manufacturing organizations in the world. The company focuses on sectors such as cardiac rhythm management, neuromodulation, and cardio and vascular markets. With a mission to improve patient lives through innovative, high-quality products, Integer serves as a trusted partner for medical device companies and original equipment manufacturers (OEMs).
Commitment to Innovation
Integer Holdings Corporation's brands include Greatbatch Medical and Lake Region Medical, reflecting its commitment to delivering innovative solutions. The company continues to prioritize customer trust and partnerships, as stated in their recent corporate communications.
Frequently Asked Questions
Who is Michael Coyle?
Michael Coyle is a seasoned executive with over 40 years in the medical device industry, recently appointed to the Board of Directors at Integer Holdings Corporation.
What is Integer Holdings Corporation known for?
Integer Holdings Corporation is one of the world's leading medical device contract development and manufacturing organizations.
What roles has Michael Coyle held in the past?
Coyle has been president and CEO of iRhythm Technologies and has held executive positions at Medtronic, St. Jude Medical, and Eli Lilly.
What qualifications does Michael Coyle have?
Coyle earned an MBA from the Wharton School and holds a bachelor's degree from Case Western Reserve University, along with several patents in the medical field.
What are Integer's core industries?
Integer primarily operates in the cardiac rhythm management, neuromodulation, and cardio and vascular markets, focusing on enhancing patient care.
